Drugs / Umbilical cord blood unit with C3a fragment
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00963872 | Mar 2010 → Aug 2012 | leukemia, myelodysplastic syndrome, plasma cell myeloma | Masonic Cancer Center, University of Minnesota | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Umbilical cord blood unit with C3a fragment | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00963872 ↗ |
| Route | Intravenous | “the C3a primed UCB unit will be infused intravenously SECOND” NCT00963872 ↗ |